Cover Image
市場調查報告書

細菌性肺炎:全球臨床實驗檢討

Bacterial Pneumonia Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 319591
出版日期 內容資訊 英文 142 Pages
訂單完成後即時交付
價格
Back to Top
細菌性肺炎:全球臨床實驗檢討 Bacterial Pneumonia Global Clinical Trials Review, H2, 2014
出版日期: 2014年11月17日 內容資訊: 英文 142 Pages
簡介

本報告提供細菌性肺炎的臨床試驗相關的基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,臨床試驗的主要製藥企業及研究機關簡介等資料。

簡介

  • 細菌性肺炎
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5個國家的臨床實驗數量
    • 歐洲主要5個國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲的主要5個國家臨床實驗數量
    • 中南美的主要5個國家臨床實驗數量

G7各國臨床實驗數量:感染疾病治療藥臨床實驗上細菌性肺炎所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:感染疾病治療藥臨床實驗上細菌性肺炎所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

細菌性肺炎治療藥臨床實驗的主要參與企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • GlaxoSmithKline plc
    • Pfizer Inc.
    • Actavis plc
    • Sanofi
    • Cempra, Inc.
    • Jacobus Pharmaceutical Company
    • AstraZeneca PLC
    • U.S. Bioscience, Inc
    • Cubist Pharmaceuticals, Inc.
    • Bayer AG
  • 有代表性的研究機關·醫院臨床實驗概要
    • The National Institute of Allergy and Infectious Diseases
    • Pharmaceutical Research Unit, Jordan
    • National Heart, Lung, and Blood Institute
    • University of Pittsburgh
    • Hospital Universitario Virgen del Rocio
    • National Taiwan University Hospital
    • University of Milan
    • National Institutes of Health Clinical Center
    • University of Oxford
    • National Center for Research Resources

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2420CTIDB

GlobalData's clinical trial report, "Bacterial Pneumonia Global Clinical Trials Review, H2, 2014" provides data on the Bacterial Pneumonia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bacterial Pneumonia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bacterial Pneumonia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Bacterial Pneumonia
    • Report Guidance
    Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Bacterial Pneumonia to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Bacterial Pneumonia to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Bacterial Pneumonia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Bacterial Pneumonia Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Bacterial Pneumonia
    • Sep 11, 2014: Genocea Commences Phase 2a Trial for GEN-004, Universal Pneumococcal Vaccine Candidate
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Actavis plc
      • Clinical Trial Overview of Actavis plc
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Cempra, Inc.
      • Clinical Trial Overview of Cempra, Inc.
      • Jacobus Pharmaceutical Company
      • Clinical Trial Overview of Jacobus Pharmaceutical Company
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • U.S. Bioscience, Inc
      • Clinical Trial Overview of U.S. Bioscience, Inc
      • Cubist Pharmaceuticals, Inc.
      • Clinical Trial Overview of Cubist Pharmaceuticals, Inc.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • Pharmaceutical Research Unit, Jordan
      • Clinical Trial Overview of Pharmaceutical Research Unit, Jordan
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • University of Pittsburgh
      • Clinical Trial Overview of University of Pittsburgh
      • Hospital Universitario Virgen del Rocio
      • Clinical Trial Overview of Hospital Universitario Virgen del Rocio
      • National Taiwan University Hospital
      • Clinical Trial Overview of National Taiwan University Hospital
      • University of Milan
      • Clinical Trial Overview of University of Milan
      • National Institutes of Health Clinical Center
      • Clinical Trial Overview of National Institutes of Health Clinical Center
      • University of Oxford
      • Clinical Trial Overview of University of Oxford
      • National Center for Research Resources
      • Clinical Trial Overview of National Center for Research Resources
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Region, 2014*
  • Bacterial Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Bacterial Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Bacterial Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Bacterial Pneumonia Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Bacterial Pneumonia Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Bacterial Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cempra, Inc., 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Jacobus Pharmaceutical Company, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Bioscience, Inc, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cubist Pharmaceuticals, Inc., 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmaceutical Research Unit, Jordan, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitario Virgen del Rocio, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Milan, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institutes of Health Clinical Center, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014*

List of Figures

  • Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Bacterial Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Bacterial Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Bacterial Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2014*
  • Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Bacterial Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Bacterial Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top